Loading
A phase 3 trial of carboplatin, paclitaxel / nab-paclitaxel and atezolizumab in lung cancer, run by Intergroupe Francophone de Cancerologie Thoracique, active but no longer recruiting.
Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy is a phase 3, randomised interventional study registered as NCT03977194 by Intergroupe Francophone de Cancerologie Thoracique, with a registry enrolment figure of 510 participants, started 2019-07-23 and due to reach its primary completion in 2024-08-31. Interventions recorded: Carboplatin; Paclitaxel; Atezolizumab. Conditions listed: Non Small Cell Lung Cancer Metastatic. Primary outcome: Overall Survival. Lung eligibility wording from the registry: "Histologically confirmed NSCLC". Sites: France. No results are recorded here; the registry entry is the source.
Shares Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin, Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin, Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Atezolizumab, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.